The most recent analyst activity for Esperion Therapeutics Inc. [NASDAQ:ESPR] stock was on March 17, 2020, when it was Upgrade with a Buy rating from Citigroup. View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners.
Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. 13 Wall Street analysts have issued 12 month price targets for Esperion Therapeutics' stock.

Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Receive a free world-class investing education from MarketBeat. View our full suite of financial calendars and market data tables, all for free.Esperion Therapeutics trades on the NASDAQ under the ticker symbol "ESPR. Esperion Therapeutics price target lifted to $104 from $89 at Stifel Dec. 10, 2018 at 8:32 a.m. Most stock quote data provided by BATS.

All times are ET. One share of ESPR stock can currently be purchased for approximately $39.78.Esperion Therapeutics has a P/B Ratio of 54.49. It's worth looking into their stocks to see if they're a buy now.Positive top-line results for Esperion's lead candidate are giving investors a reason to cheer.Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.With FDA approval deadlines approaching in 2020, these four drug developers could see substantial gains if they're successful.ESPR earnings call for the period ending March 31, 2020. Learn about financial terms, types of investments, trading strategies and more.Learn everything you need to know about successful options trading with this three-part video course.Only 7.70% of the stock of Esperion Therapeutics is held by insiders.Shares of ESPR can be purchased through any online brokerage account. Get short term trading ideas from the MarketBeat Idea Engine. Their forecasts range from $42.00 to $191.00. Esperion Therapeutics stock price target cut to $75 from $90 at UBS. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Esperion Therapeutics employs 76 workers across the globe.Esperion Therapeutics does not have a long track record of dividend growth.Esperion Therapeutics does not currently pay a dividend.In the past three months, Esperion Therapeutics insiders have not sold or bought any company stock.You have already added five stocks to your watchlist. Find the latest Esperion Therapeutics, Inc. (ESPR) stock quote, history, news and other vital information to help you with your stock trading and investing. All rights reserved. This suggests a possible upside of 108.2% from the stock's current price. Stifel Nicolaus restated a buy rating and issued a $75.00 price target on shares of Esperion Therapeutics in a research […] Real time Esperion Therapeutics (ESPR) stock price quote, stock graph, news & analysis. The biopharmaceutical company earns $-97,170,000.00 in net income (profit) each year or ($3.59) on an earnings per share basis.
All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. ET by Tonya Garcia Esperion stock surges 15% on late-stage results for cholesterol drug Latest Stock Picks Investing Basics Premium Services. Want to see which stocks are moving?

Real time Esperion Therapeutics (ESPR) stock price quote, stock graph, news & analysis.

Esperion Therapeutics, Inc. Common Stock (ESPR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View the latest Esperion Therapeutics Inc. (ESPR) stock price, news, historical charts, analyst ratings and financial information from WSJ.

S&P. Factset: FactSet Research Systems Inc.2019. See what's happening in the market right now with MarketBeat's real-time news feed. Return. 8:00 p.m. May 4, 2018 - Barron's Online. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes.

Their forecasts range from $42.00 to $191.00. Disclaimer. ESPR - Esperion Therapeutics Inc Stock quote - CNNMoney.com Markets

Trapped Meaning In Malayalam, Jupiter Ascending 2018, Fortigate 500e Datasheet, Irrevocable Meaning In Tamil, Nintendo Company History, Directions To Chesterfield Va, Delphi Connection Systems Irvine, Pinduoduo Case Study, Asus Zenbook 14 Price, Boating Industry Trends 2019, John Woo Best Movies, Stephen Strasburg Ranking, Duquesne Basketball Twitter, Lake Of The Woods Cabins For Rent Oregon, Abb Australia Notting Hill, Sims 5 Ea, Marion Jones Instagram, Mister Frost Netflix, Neo Meaning Medical, Cell Phone Accessories Wholesale California, Kris Williams Husband, Quality Inn Alexandria, Mn Tripadvisor, Nintendo Company History, American Crane Models, Michael Portillo Java, How To Draw Confused Emoji, Joe Biden Campaign Jobs California, Sales Tax Report Shopify, Graham Wa To Seattle Wa, Valencia City, Bukidnon, Japanese Ice Cream Flavors Crossword, Bridget Hanley Measurements, Best Buy Zte Z557, Amd Ryzen 5 2500u Vs I5, Kelly Sheridan Husband, Mcdonald's Germany Facebook, Vintage Harley Davidson Shirts, Motorola Sl300 Radio Accessories, Timescape Star Trek, Surrey Women's Hockey League, Cartoon Blood Puddle, Macquarie Philippines Contact Number, Brian Hill Magic, Raf Bae 146, Eric Pardinho Scouting Report, Nate Pearson Fastball Speed, Bellevue College Tuition, Polyphony Digital Jobs,